---
figid: PMC6600524__ijms-20-02802-g001
figlink: /pmc/articles/PMC6600524/figure/ijms-20-02802-f001/
number: Figure 1
caption: Schematic representation of androgen deprivation therapy (ADT) or androgen
  receptor (AR) antagonist in mediating therapeutic resistance and neuroendocrine
  (NE) differentiation of prostate cancer (PCa). Inactivates of the AR–SAM pointed
  domain-containing ETS transcriptional factor (SPDEF) signaling pathway via AR antagonist
  or by ADT induce the expression of ZBTB46, TGFBI, and CCL2 (Left). ZBTB46 acts as
  a transcriptional inducer for LIF, PTGS1, and Snail, which further enhance tumor
  progression, metastasis, therapeutic resistance, and castration-resistant PCa (CRPC)-NE
  differentiation of PCa (Right).
pmcid: PMC6600524
papertitle: 'ZBTB46, SPDEF, and ETV6: Novel Potential Biomarkers and Therapeutic Targets
  in Castration-Resistant Prostate Cancer.'
reftext: AbdulFattah Salah Fararjeh, et al. Int J Mol Sci. 2019 Jun;20(11):2802.
pmc_ranked_result_index: '20299'
pathway_score: 0.9299335
filename: ijms-20-02802-g001.jpg
figtitle: Schematic representation of androgen deprivation therapy (ADT) or androgen
  receptor (AR) antagonist in mediating therapeutic resistance and neuroendocrine
  (NE) differentiation of prostate cancer (PCa)
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6600524__ijms-20-02802-g001.html
  '@type': Dataset
  description: Schematic representation of androgen deprivation therapy (ADT) or androgen
    receptor (AR) antagonist in mediating therapeutic resistance and neuroendocrine
    (NE) differentiation of prostate cancer (PCa). Inactivates of the AR–SAM pointed
    domain-containing ETS transcriptional factor (SPDEF) signaling pathway via AR
    antagonist or by ADT induce the expression of ZBTB46, TGFBI, and CCL2 (Left).
    ZBTB46 acts as a transcriptional inducer for LIF, PTGS1, and Snail, which further
    enhance tumor progression, metastasis, therapeutic resistance, and castration-resistant
    PCa (CRPC)-NE differentiation of PCa (Right).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CCL2
  - KIR3DL1
  - AR
  - PTGS1
  - SNAI1
  - LIF
  - ZBTB46
  - SPDEF
  - TGFBI
  - Testosterone
  - cancer
genes:
- word: CCL2
  symbol: CCL2
  source: hgnc_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
- word: ↑CL2
  symbol: cl-2
  source: hgnc_alias_symbol
  hgnc_symbol: KIR3DL1
  entrez: '3811'
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: LIF,PTGS1,,
  symbol: PTGS1
  source: hgnc_symbol
  hgnc_symbol: PTGS1
  entrez: '5742'
- word: Snail
  symbol: SNAIL
  source: hgnc_alias_symbol
  hgnc_symbol: SNAI1
  entrez: '6615'
- word: LIF,PTGS1,,
  symbol: LIF
  source: hgnc_symbol
  hgnc_symbol: LIF
  entrez: '3976'
- word: ZBTB46
  symbol: ZBTB46
  source: hgnc_symbol
  hgnc_symbol: ZBTB46
  entrez: '140685'
- word: SPDEF
  symbol: SPDEF
  source: hgnc_symbol
  hgnc_symbol: SPDEF
  entrez: '25803'
- word: TGFBI
  symbol: TGFBI
  source: hgnc_symbol
  hgnc_symbol: TGFBI
  entrez: '7045'
chemicals:
- word: Testosterone
  source: MESH
  identifier: D013739
diseases:
- word: cancer
  source: MESH
  identifier: D009369
---
